The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
Back to Top News
Top
August 17, 2026 at 4:48 PM
AstraZeneca ditches lung cancer treatment trial
Evening Standard